Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials Joseph MellorDmitry KuznetsovHelen M. Colhoun Article Open access 25 May 2024
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study Jolien De MeulemeesterSara CharleerPieter Gillard Article 24 May 2024
Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention Reiner Jumpertz von SchwartzenbergElsa Vazquez ArreolaAndreas L. Birkenfeld Research Letter Open access 23 May 2024
Heterogeneity of glycaemic phenotypes in type 1 diabetes Guy FagherazziGloria A. Aguayoon behalf of the SFDT1 study team Article Open access 23 May 2024
Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes? André Pontes-SilvaAldair Darlan Santos-de-AraújoAndré L. Lopes Letter 22 May 2024
Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality Aleksander L. HansenCharlotte BrønsAllan Vaag Article Open access 22 May 2024
Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL Jill CarltonPhilip A. PowellDonna Rowen Article Open access 22 May 2024
Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study Shuai YuanDan LefflerJonas F. Ludvigsson Article Open access 21 May 2024
Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults Danielle E. HaslamLiming LiangShilpa N. Bhupathiraju Article 21 May 2024
2024: The year to take European action on diabetes to the next level Stefano Del PratoBart Torbeynson behalf of the European Diabetes Forum Board News 18 May 2024
Bone metabolism in diabetes: a clinician’s guide to understanding the bone–glucose interplay Angela SheuChristopher P. WhiteJacqueline R. Center Review Open access 18 May 2024
RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function Hazem IbrahimDiego BalboaTimo Otonkoski Extended Article Open access 14 May 2024
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial Søren GullaksenLiv VernstrømEsben Laugesen Correction 13 May 2024
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sánchez‑Hernández and Wägner [letter] Willemijn E. CorpeleijnWouter J. de WaalAlbert Wiegman Letter 13 May 2024
The role of automated insulin delivery technology in diabetes Charlotte K. BoughtonRoman Hovorka Review Open access 13 May 2024
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study Marie Winther-SørensenSara L. GarciaNicolai J. Wewer Albrechtsen Article Open access 06 May 2024
New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus Bart Van der SchuerenPatrick VrijlandtKristina Dunder News 04 May 2024
Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial Yukari KobayashiJin LongLatha Palaniappan Correction 30 April 2024
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes Roberto TrevisanMatteo ContiStefano Ciardullo Review Open access 29 April 2024
ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes Jingfang ChenQi FengZhangsuo Liu Article 27 April 2024
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials Sofia Sterner IsakssonHenrik ImbergMarcus Lind Article Open access 26 April 2024
Exercise-induced increase in muscle insulin sensitivity in men is amplified when assessed using a meal test Christian T. VoldstedlundKim A. SjøbergErik A. Richter Article Open access 25 April 2024
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes Guy S. TaylorKieran SmithLee D. Roberts Article Open access 25 April 2024
Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study Christian J. BrakenridgeAnnemarie KosterDavid W. Dunstan Article Open access 24 April 2024
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18F-FDG-PET/MRI Jan W. ErikssonMaria J. PereiraHåkan Ahlström Article Open access 24 April 2024
Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus Sara DenicolòVera ReinstadlerGert Mayer Article Open access 22 April 2024
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial Ji Yoon KimSang-Man JinJae Hyeon Kim Article 19 April 2024
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial Ji Yoon KimSang-Man JinJae Hyeon Kim Article 18 April 2024
A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation Adrian VillalbaYorick GittonRaphaël Scharfmann Article Open access 17 April 2024 Pages: 1066 - 1078
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities Simona SaccoMatteo FoschiMichele Romoli Review Open access 16 April 2024
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes Xinyu LiLouise A. DonnellyTalitha Feenstra Article Open access 16 April 2024
Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden Johanna MetsäläKari RisnesEero Kajantie Article Open access 13 April 2024
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials Thomas KaragiannisKonstantinos MalandrisEleni Bekiari Article Open access 13 April 2024
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database Aikaterini EleftheriadouDavid RileyUazman Alam Article Open access 08 April 2024
Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England Jonathan ValabhjiNaomi HolmanKetan Dhatariya Article Open access 08 April 2024
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology Aleksey MatveyenkoAdrian Vella Letter 06 April 2024
Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy Eva Sierra‑SilvestreRicardo J. AndradeMichel W. Coppieters Correction Open access 05 April 2024
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology. Reply to Matveyenko A, Vella A [letter] Nikhil R. GandasiPatrik Rorsman Letter 05 April 2024
Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring Yaxin WangSiwan LiJian Zhou Article Open access 03 April 2024
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study Cong XiePeter IrogaTongzhi Wu Article Open access 01 April 2024
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial Ditte S. KornumDavide BertoliAsbjørn M. Drewes Article Open access 28 March 2024 Pages: 1122 - 1137
Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial Elske L. van den BurgMarjolein P. SchoonakkerHanno Pijl Article Open access 28 March 2024
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults M. Loredana MarcovecchioA. Emile J. Hendrikson behalf of the INNODIA consortium Article Open access 22 March 2024 Pages: 995 - 1008
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity Vanessa YuFiona YongSteven J. Millership Article Open access 21 March 2024 Pages: 1079 - 1094
Effectiveness and safety of empagliflozin: final results from the EMPRISE study Phyo T. HtooHelen TesfayeElisabetta Patorno Article 21 March 2024
CK2 activity is crucial for proper glucagon expression Emmanuel AmpofoMandy PackClaudia Götz Extended Article Open access 20 March 2024
No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts Nicolai A. Lund-BlixAnne A. BjerregaardLars C. Stene Short Communication Open access 19 March 2024 Pages: 1023 - 1028
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort Lauren V. TurnerMartin Chase Marakfor the T1DEXI Study Group Article 19 March 2024 Pages: 1009 - 1022
